Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010

BMJ Open

Volumn 4, Issue 1, 2014, Pages

  Head, Michael G ^a   Fitchett, Joseph R ^b   Atun, Rifat ^c,d   May, Robin C ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL RESISTANCE; FUNDING; HEALTH CARE ORGANIZATION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION; INVESTMENT; MEDICAL RESEARCH; MYCOLOGY; OUTCOME ASSESSMENT; REVIEW; UNITED KINGDOM; ECONOMICS; FINANCIAL MANAGEMENT; MYCOSIS; TIME FACTOR;

BIOMEDICAL RESEARCH; HUMANS; MYCOLOGY; MYCOSES; RESEARCH SUPPORT AS TOPIC; TIME FACTORS; UNITED KINGDOM;

EID: 84892897287     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004129     Document Type: Review

References (12)

1. Leading International Fungal Education. Burden of fungal infection abstracts. In: 12th European Congress on Clinical Microbiology and Infectious Diseases. Berlin, 2013. http://www.life-worldwide.org/assets/uploads/files/ ECCMID global Burden abstracts final Nov 2012 3.pdf
2. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23:525-30.
3. Brown GD, Denning DW, Gow NAR, et al. Hidden killers: human fungal infections. Sci Transl Med 2012;4:165rv13.
4. Brown J, Benedict K, Park BJ, et al. Coccidioidomycosis: epidemiology. Clin Epidemiol 2013;5:185-97.
5. Ghosh S, Hoselton SA, Dorsam GP, et al. Eosinophils in fungus-associated allergic pulmonary disease. Front Pharmacol 2013;4:8.
6. Pakdaman MN, Corry DB, Luong A. Fungi linking the pathophysiology of chronic rhinosinusitis with nasal polyps and allergic asthma. Immunol Invest 2011;40:767-85.
7. Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science 2012;336:647.
8. Head MG, Fitchett JR, Cooke MK, et al. UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 2012. http://www.ncbi.nlm.nih.gov/pubmed/23140942 (accessed 17 Nov 2012).
9. Research Investments.org. http://www.researchinvestments.org/ (accessed 30 May 2012).
10. Iñigo M, Pemán J, Del Pozo JL. Antifungal activity against Candida biofilms. Int J Artif Organs 2012;35:780-91.
11. Vermeulen E, Cooreman S, Maertens J, et al. Azole resistance in Aspergillus: an emerging problem? Acta Clin Belg 2012;67: 322-7.
12. Head MG, Fitchett JR, Cooke MK, et al. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother 2013. http://www.ncbi.nlm.nih.gov/pubmed/ 24038777 (accessed 26 Sep 2013).